← FDA Drug Approvals (Drugs@FDA)

DESMOPRESSIN ACETATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: UBI · Approved 2020-09-17

Drug application

FDA Application #

ANDA210223

Application type

Abbreviated New Drug Application (Generic)

Brand name

DESMOPRESSIN ACETATE

Generic name

DESMOPRESSIN ACETATE

Active ingredients

DESMOPRESSIN ACETATE

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Prescription

Sponsor

UBI

Manufacturer

Avenacy, Inc.

First approval

2020-09-17

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown